Home » Archive by Category

News

Original content and news from BioSpace, Xconomy, Marketwire and other sources, specific to the region.

Clinical Trial to Test Safety of Drug Targeting Leukemia Cells

September 3, 2014 – 12:45 pm | Edit Post

Researchers at the University of California, San Diego School of Medicine, in partnership with the California Institute for Regenerative Medicine (CIRM) and Celgene Corporation, a New Jersey-based biopharmaceutical company, have launched a phase 1 huma…

Powerful anti-HIV antibody found

September 3, 2014 – 10:00 am | Edit Post

Newly discovered weak spot on HIV also found in study published in Nature.

Powerful anti-HIV antibody found

September 3, 2014 – 10:00 am | Edit Post

Newly discovered weak spot on HIV also found in study published in Nature.

The Celsius Quiz this week – did you choose the right career?

September 3, 2014 – 8:18 am | Edit Post

This week’s Celsius quiz will help you answer the question if you picked the right career.

The Celsius Quiz this week – did you choose the right career?

September 3, 2014 – 8:18 am | Edit Post

This week’s Celsius quiz will help you answer the question if you picked the right career.

AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug

September 3, 2014 – 4:56 am | Edit Post
AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug

It’s been a topsy-turvy few years for Infinity Pharmaceuticals. The Cambridge, MA-based company is well behind a few others, whose rival blood cancer drugs that have already made it to market, and…

[[Click headline to continue reading.]]

AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug

September 3, 2014 – 4:56 am | Edit Post
AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug

It’s been a topsy-turvy few years for Infinity Pharmaceuticals. The Cambridge, MA-based company is well behind a few others, whose rival blood cancer drugs that have already made it to market, and…

[[Click headline to continue reading.]]

AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug

September 3, 2014 – 4:56 am | Edit Post
AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug

It’s been a topsy-turvy few years for Infinity Pharmaceuticals. The Cambridge, MA-based company is well behind a few others, whose rival blood cancer drugs that have already made it to market, and…

[[Click headline to continue reading.]]

Feds Provide Funding, Expertise to Advance ZMapp Drug for Ebola

September 2, 2014 – 6:37 pm | Edit Post
Feds Provide Funding, Expertise to Advance ZMapp Drug for Ebola

The U.S. Department of Health and Human Services said today it would provide its expertise and as much as $42.3 million to help San Diego-based Mapp Biopharmaceutical accelerate development and…

[[Click headline to continue reading.]]

Feds Provide Funding, Expertise to Advance ZMapp Drug for Ebola

September 2, 2014 – 6:37 pm | Edit Post
Feds Provide Funding, Expertise to Advance ZMapp Drug for Ebola

The U.S. Department of Health and Human Services said today it would provide its expertise and as much as $42.3 million to help San Diego-based Mapp Biopharmaceutical accelerate development and…

[[Click headline to continue reading.]]